Lymphedema, Secondary
16
2
4
10
Key Insights
Highlights
Success Rate
91% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
6.3%
1 terminated out of 16 trials
90.9%
+4.4% vs benchmark
0%
0 trials in Phase 3/4
20%
2 of 10 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 10 completed trials
Clinical Trials (16)
A Study Evaluating an Advanced Pneumatic Compression Device Versus Usual Care for Treatment of Head and Neck Lymphedema
The N-LVA Study: RCT Comparing LVA vs. Sham Surgery in Cancer-related Lymphedema
Imaging Sodium and Lymphatics in Lymphedema
Lymphovenous Anastomosis for Breast Cancer Lymphedema
LymphoPilot Test for Limb Lymphedema
Reconstruction of Cervical Lymphatic System During Head and Neck Squamous Cell Carcinoma Surgery
Adjustable Compression Wrap Versus Compression Bandage Reduce to Breast Cancer-related Lymphedema
Reduction of Arm Volume and Improvement in Lymphedema Via Surgery
The Robot-LVA Study: Robot-assisted Microsurgical Lymphaticovenous Anastomosis in Breast Cancer-related Lymphedema
Adjustable Compression Wrap Versus Compression Sleeve to Control Breast Cancer-related Lymphedema
Physiological Study to Assess Mechanism of Action of MOBIDERM® in Lower-limb Lymphedema Patients
A Preference Study of Two Pneumatic Compression Devices for Patients With Lower Limb Lymphedema
Skin Biophysical Measures for Assessing Head and Neck Cancer-Related External Lymphedema
Treatment of Breast Cancer-related Lymphedema With a Negative Pressure Device
Secondary Lymphedema Due to Human Adjuvant Disease
Effect of Lifestyle Intervention vs Physical Therapy Treatment in Patients With Secondary Lymphedema After Cancer